LEGN vs. TEVA, ITCI, GMAB, SMMT, RDY, ASND, MRNA, VTRS, QGEN, and BPMC
Should you be buying Legend Biotech stock or one of its competitors? The main competitors of Legend Biotech include Teva Pharmaceutical Industries (TEVA), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Summit Therapeutics (SMMT), Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), Moderna (MRNA), Viatris (VTRS), Qiagen (QGEN), and Blueprint Medicines (BPMC). These companies are all part of the "pharmaceutical products" industry.
Legend Biotech vs.
Teva Pharmaceutical Industries (NYSE:TEVA) and Legend Biotech (NASDAQ:LEGN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.
Legend Biotech has lower revenue, but higher earnings than Teva Pharmaceutical Industries. Legend Biotech is trading at a lower price-to-earnings ratio than Teva Pharmaceutical Industries, indicating that it is currently the more affordable of the two stocks.
Teva Pharmaceutical Industries currently has a consensus target price of $24.44, suggesting a potential upside of 38.85%. Legend Biotech has a consensus target price of $76.20, suggesting a potential upside of 102.44%. Given Legend Biotech's higher possible upside, analysts plainly believe Legend Biotech is more favorable than Teva Pharmaceutical Industries.
Teva Pharmaceutical Industries has a net margin of -9.91% compared to Legend Biotech's net margin of -66.92%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Legend Biotech's return on equity.
Teva Pharmaceutical Industries has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500. Comparatively, Legend Biotech has a beta of 0.13, indicating that its stock price is 87% less volatile than the S&P 500.
54.0% of Teva Pharmaceutical Industries shares are held by institutional investors. Comparatively, 70.9% of Legend Biotech shares are held by institutional investors. 0.5% of Teva Pharmaceutical Industries shares are held by insiders. Comparatively, 0.0% of Legend Biotech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Teva Pharmaceutical Industries received 1250 more outperform votes than Legend Biotech when rated by MarketBeat users. However, 73.02% of users gave Legend Biotech an outperform vote while only 67.95% of users gave Teva Pharmaceutical Industries an outperform vote.
In the previous week, Teva Pharmaceutical Industries had 7 more articles in the media than Legend Biotech. MarketBeat recorded 16 mentions for Teva Pharmaceutical Industries and 9 mentions for Legend Biotech. Legend Biotech's average media sentiment score of 0.62 beat Teva Pharmaceutical Industries' score of 0.26 indicating that Legend Biotech is being referred to more favorably in the news media.
Summary
Teva Pharmaceutical Industries beats Legend Biotech on 11 of the 19 factors compared between the two stocks.
Get Legend Biotech News Delivered to You Automatically
Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Legend Biotech Competitors List
Related Companies and Tools
This page (NASDAQ:LEGN) was last updated on 6/10/2025 by MarketBeat.com Staff
